Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.1314 USD
−5.02 M USD
0.00 USD
18.20 M
About ALGERNON PHARMACEUTICALS INC.
Sector
CEO
Christopher Joseph Moreau
Headquarters
Vancouver
Website
Founded
2015
FIGI
BBG00C82WPQ1
Algernon Pharmaceuticals, Inc. is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them into new human trials, developing new formulations and seeking new regulatory approvals in global markets. It specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AGNPF is 0.0414 USD — it has increased by 0.98% in the past 24 hours. Watch Algernon Pharmaceuticals Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Algernon Pharmaceuticals Inc. stocks are traded under the ticker AGNPF.
AGNPF stock has fallen by −0.72% compared to the previous week, the month change is a −26.86% fall, over the last year Algernon Pharmaceuticals Inc. has showed a −20.96% decrease.
AGNPF reached its all-time high on Jan 9, 2018 with the price of 20.9450 USD, and its all-time low was 0.0353 USD and was reached on Nov 17, 2023. View more price dynamics on AGNPF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AGNPF stock is 24.67% volatile and has beta coefficient of 1.15. Track Algernon Pharmaceuticals Inc. stock price on the chart and check out the list of the most volatile stocks — is Algernon Pharmaceuticals Inc. there?
Today Algernon Pharmaceuticals Inc. has the market capitalization of 991.46 K, it has increased by 6.55% over the last week.
Yes, you can track Algernon Pharmaceuticals Inc. financials in yearly and quarterly reports right on TradingView.
Algernon Pharmaceuticals Inc. is going to release the next earnings report on Jan 23, 2025. Keep track of upcoming events with our Earnings Calendar.
AGNPF net income for the last quarter is 1.06 M USD, while the quarter before that showed −739.13 K USD of net income which accounts for 243.29% change. Track more Algernon Pharmaceuticals Inc. financial stats to get the full picture.
No, AGNPF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AGNPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Algernon Pharmaceuticals Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Algernon Pharmaceuticals Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Algernon Pharmaceuticals Inc. stock shows the sell signal. See more of Algernon Pharmaceuticals Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.